tumor necrosis factor-␣; tumor necrosis factor receptor; patch clamp; alveolar epithelial cell; acute lung injury; pulmonary edema; pneumonia ALVEOLAR EPITHELIAL FLUID transport is a fundamental mechanism for the resolution of alveolar edema (7, 12, 14, 35, 37, 38, 41, 42) . Because of their location, alveolar epithelial cells are often exposed to increased intracellular and extracellular concentrations of reactive oxygen and nitrogen species and inflammatory cytokines such as tumor necrosis factor (TNF)-␣. Several studies (8, 45, 46, 48, 52, 55) have demonstrated that TNF-␣ may have either a deleterious or a protective effect during the inflammatory response after infection (53, 54) . Rezaiguia et al. (44) reported that acute Pseudomonas aeruginosa pneumonia resulted in a marked upregulation of the rate of net alveolar epithelial Na ϩ and fluid clearance in rats, an effect that depended on TNF-␣ stimulation of alveolar fluid transport. A recent study (10) also reported that TNF-␣ mediates upregulated alveolar fluid clearance (AFC) in rats with septic peritonitis. TNF-␣ may also upregulate nitric oxide production by inflammatory cells (1, 22, 28, 50) , an effect that could have several effects on ion transport (15, 16, 23) .
To investigate the mechanisms by which TNF-␣ upregulates AFC, we carried out both in vivo and isolated cell studies. First, using intact rats, we determined whether intratracheal instillation of TNF-␣ increased AFC by amiloride-sensitive mechanisms in rats and whether the TNF-␣ effect in rats was inhibited by a ␤-antagonist or accelerated by a ␤-agonist. Also, to gain insight into how TNF-␣ may upregulate AFC, we carried out experiments in rats with a triple-mutant TNF-␣ that lacks the lectinlike region of the molecule that is responsible for the membrane conductanceactivating effect of the molecule (26, 33) ; the triple mutant also has a modest decrease in binding to the two known TNF-␣ receptors TNFRI and TNFRII (32) . To elucidate the mechanisms of TNF-␣ action, we measured Na ϩ currents across A549 cells, a human alveolar epithelial cell line that possesses many characteristics of type II cells, including Na ϩ -selective amiloride-sensitive channels (31) , patched in the whole mode. These measurements were performed before and after perfusion of A549 cells with TNF-␣, TNF-␣ plus amiloride, or the triple-mutant TNF-␣ and across A549 cells preincubated with blocking antibodies to TNFRI and TNFRII before perfusion with TNF-␣.
MATERIALS AND METHODS
Male Sprague-Dawley rats (n ϭ 46; 250-350 g) were used for all animal experiments. The rats were housed in airfiltered, temperature-controlled units with food and water. All procedures were approved by the University of California, San Francisco Committee on Animal Research.
Surgical Preparation for AFC Measurements
Rats were anesthetized with pentobarbital sodium (50-100 mg/kg ip). A tracheostomy was done, and a 0.2-mminternal diameter endotracheal tube (PE-240, Clay Adams, Becton Dickinson, Parsippany, NJ) was inserted. The rats were maintained in the right decubitus position and ventilated (Harvard Apparatus, Millis, MA) with 100% O 2, peak airway pressure of 12-15 cmH2O, and positive end-expiratory pressure of 3 cmH2O. The respiratory rate was adjusted to maintain arterial PCO2 between 35 and 45 mmHg. A catheter was inserted into the right carotid artery to monitor systemic blood pressure and obtain blood samples. Body temperature was always kept constant at 38°C by placing the animals on a thermostatically controlled pad. This protocol was according to previous studies by Jayr et al. (27) and Rezaiguia et al. (44) .
Preparation of the Instillate
A 5% isosmolar bovine serum albumin (BSA; Sigma, St. Louis, MO) solution with Ringer lactate was prepared according to previous reports (24, 30, 49) . We added 1 mg of anhydrous Evans blue dye and 0.5 Ci of 125 I-labeled human serum albumin (Merck-Frosst, Montreal, PQ) to the instillate. In some studies, 10 Ϫ3 M amiloride (Sigma), 10 Ϫ4 M terbutaline (Sigma), 10 Ϫ4 M propranolol (Sigma), wild-type TNF-␣ (5 g/rat; Innogenetics, Ghent, Belgium), or a tripleamino acid lectin-deficient mutant of TNF-␣ (5 g/rat) was added into the instillate. A sample of the instillate was obtained for measurement of total protein, 125 I radioactivity, and water-to-dry weight ratio.
TNF-␣
Wild-type mouse TNF-␣ and the triple-amino acid mutant mouse TNF-␣ were provided by Innogenetics. The triplemutant TNF-␣ was generated by amino acid replacement of residues Thr 104 , Glu 106 , and Glu 109 by alanine in the lectinlike domain of the molecule situated in the tip region the TNF trimer. This portion of the molecule is responsible for the Na ϩ channel-activating capacity (26) , and this mutant was originally developed to study the role of the lectinlike domain of TNF-␣ (32). Also, the mutant does have a 5-fold reduced receptor affinity for TNFR1 and a 10-fold reduced receptor affinity for TNFR2 (32) .
General Protocol
A 1-h baseline period of stable blood pressure and heart rate was required before alveolar fluid instillation.
131 I-labeled albumin (3 Ci) was injected intravenously as a vascular tracer 15 min before instillation. The vascular tracer was used to calculate the flux of plasma protein into the airspaces (27) . Blood samples were obtained every 30 min during the experiment for 131 I-albumin and 125 I-albumin radioactivity and arterial blood gas determinations. We instilled 6 ml/kg of isosmolar fluid into both lungs. At the end of studies (60 min), the rats were exsanguinated and the lungs were removed through a midline sternotomy. An alveolar fluid sample (0.1-0.2 ml) was aspirated with a 3-ml syringe and Silastic tubing that was passed into a wedged position in both lungs. Total protein and radioactivity of the alveolar fluid sample were measured. The lungs were homogenized for extravascular lung water measurements and radioactivity counts.
Specific Protocols: Rat Studies
Basal alveolar fluid clearance was determined in group 1 (n ϭ 4 rats). The effects of TNF-␣ (5 g/rat; n ϭ 7 rats) and (1 g/rat; n ϭ 4 rats) and the triple-mutant TNF-␣ (5 g/rat; n ϭ 5 rats) on AFC were studied in group 2. The effect of amiloride (10 Ϫ3 M; n ϭ 5 rats) on basal AFC and the combined effect of amiloride (10 Ϫ3 M) and wild-type TNF-␣ (5 g/rat; n ϭ 6 rats) on AFC were studied in group 3. The effect of terbutaline (10 Ϫ4 M; n ϭ 5 rats) on basal AFC and the combined effect of terbutaline (10 Ϫ4 M) and wild-type TNF-␣ (n ϭ 5 rats) on AFC were studied in group 4. The effect of propranolol (10 Ϫ3 M; n ϭ 5 rats) on TNF-␣-stimulated was studied in group 5.
Measurement of AFC
According to prior studies by our laboratory (7, 18, 27, 37, 41, 44) , AFC was estimated by measuring the increase in the final concentration of the alveolar protein tracer compared with the initial instilled tracer protein concentrations. We subtracted the dry weight of the added protein in the lung water calculation from the final alveolar sample.
Patch Clamp
Cell line and culture methods. A549 cells were purchased from American Type Culture Collection (Manassas, VA) in the 76th passage. They were suspended in DMEM-F-12 medium (Cellgro) supplemented with 1% penicillin-streptomycin and 10% fetal calf serum, plated on plastic tissue culture flasks (Corning Glass Works, Corning, NY), and placed in an incubator in 21% O 2, 5% CO2, and balance N2 at 37°C and 100% humidity. All experiments were carried out on cells between the 78th and the 97th passages.
Electrophysiology, patch-clamp recording, and analysis. Macroscopic currents were recorded from A549 cells in the whole cell recording mode of the patch-clamp technique (23) .
Between 24 and 36 h before any electrophysiological measurements, the A549 cells were lifted from the tissue plates by treatment with 2.5% trypsin-EDTA (Sigma) for 3-6 min at 37°C and then seeded on 12-mm-diameter glass coverslips in DMEM-F-12 medium. The coverslip was rinsed with standard external solution (SES; 310-320 mosM) just before the onset of the measurements. The composition of SES was 145 mM NaCl, 2.7 mM KCl, 1.8 mM CaCl 2, 2.0 mM MgCl2, 5.5 mM glucose, and 10 mM HEPES, pH 7.4 (with NaOH). The cells were then transferred to the recording chamber that was mounted on the stage of an inverted microscope (IMT-2, Olympus, Tokyo, Japan) for patch-clamp recordings.
The pipettes were made from LG16-type capillary glass (Dagan, Minneapolis, MN) with a vertical puller (model PB-7, Narishige, Japan). The intrapipette solution consisted of 135 mM potassium methylsulfonic acid, 10 mM KCl, 6 mM NaCl, 1.0 mM Mg 2ATP, 2.0 mM Na3ATP, 10.0 mM HEPES, and 0.5 mM EGTA, pH 7.2 (with 1 N KOH), at 22°C (standard internal solution; 300 mosM). The pipette resistance varied from 3 to 5 M⍀ when back-filled with standard internal solution. The pipette offset potential was corrected just before gigaseal formation. Series resistance and capacitance transients were compensated for with the patch-clamp amplifier (Axopatch 200A, Axon Instruments, Foster City, CA).
The junction potentials between the pipette solution and the bath solution at the tip of the pipette and between the perfusing solution and the agar bridge were corrected for as described in a prior report (5) . The preparation was grounded with a Ag-AgCl electrode connected to the bath via an agar bridge (2%). The solution in the recording chamber (400 l) was changed with a gravity-driven perfusion system. The cell membrane potential was held at Ϫ40 mV during all whole cell recordings. Inward currents were elicited by altering the membrane potential from the holding value (Ϫ40 mV) by Ϫ100 mV for 450 ms every 5 s with the Clampex program (pCLAMP, Axon Instruments). The currents were digitized at 5 kHz with a digital-to-analog, analog-to-digital converter (DigiData 1200A, Axon Instruments), filtered through an internal four-pole Bessel filter at 2 kHz, and stored on the hard disk of a computer.
After baseline currents were recorded, A549 cells, while still patched in the whole cell mode, were perfused with SES containing either 10 or 120 ng of wild-type or triple-mutant TNF-␣ for 2-3 min, which resulted in a steady-state increase in inward Na ϩ currents. The cells were then perfused with either SES alone or SES containing 10 M amiloride for 5-8 min. Inward Na ϩ currents were measured continuously throughout this period. To further investigate the potential mechanisms by which TNF-␣ increased Na ϩ currents, A549 cells, patched in the whole cell mode, were incubated with SES containing anti-human soluble (s) TNFRI and sTNFRII antibodies (5 ng each; R&D Systems) or an equivalent amount of nonspecific mouse IgG for 3 min. The specificity of the antibodies has been demonstrated (38) . They were then perfused with the SES containing sTNFRI, sTNFRII, and 120 ng/ml of TNF-␣. Inward Na ϩ currents were measured as above.
Statistics
All data are means Ϯ SD unless otherwise noted. AFC data were analyzed by one-way ANOVA followed by Mann-Whitney U-test post hoc. Time-dependent effects were analyzed by repeated-measures ANOVA followed by Student-NewmanKeuls test post hoc. Significance was defined as P Ͻ 0.05.
RESULTS

Effect of Wild-Type TNF-␣ and Amiloride on AFC in Rats
Wild-type TNF-␣ (5 g/rat) increased AFC by 67% (P Ͻ 0.05) over 1 h in the ventilated rats. Amiloride decreased basal AFC by 41% (P Ͻ 0.05) and prevented the TNF-␣-induced upregulation of AFC (P Ͻ 0.05; Fig.  1) . A lower dose of TNF-␣ (1 g/rat) did not increase AFC (data not shown).
Effect of ␤-Adrenergic Stimulation and Blockade on AFC During TNF-␣ Instillation in Rats
Terbutaline alone increased AFC by 65% in rats (P Ͻ 0.05), similar to the effect of wild-type TNF-␣. However, the combination of terbutaline and TNF-␣ had no additional effect on AFC (Fig. 2) . Propranolol, a ␤-adrenergic receptor antagonist, did not decrease the TNF-␣-stimulated AFC in rats (Fig. 2) 
Effect of Wild-Type TNF-␣ and Triple-Mutant TNF-␣ on AFC in Rats
Wild-type TNF-␣ significantly increased AFC by 67% in ventilated rats (P Ͻ 0.05), but the triple-mutant TNF-␣ did not upregulate AFC (Fig. 3) .
Patch-Clamp Experiments on A549 Cells With Wild-Type and Triple-Mutant TNF-␣
Whole cell inward current was elicited by the application of Ϫ100 mV to cells patched in the whole cell mode and held at Ϫ40 mV. Perfusion of A549 cells with 10 ng/ml of TNF-␣ did not increase the baseline current (data not shown). However, perfusion with 120 ng/ml of TNF-␣ (n ϭ 6 cells) resulted in a large increase in the inward Na ϩ current, starting within 30 s from the start of perfusion (Fig. 4A ). This increase was sustained when the cell was reperfused with SES alone (Fig. 4A) but was completely abolished when amiloride (10 M) was added into the perfusion medium (Fig. 4B) . On the other hand, perfusion with the triple-mutant TNF-␣ (120 ng/ml) did not increase the inward currents (Fig.  5) . Perfusion with TNF-␣ in the presence of two blocking antibodies to TNFRI and TNFRII failed to increase the inward current (Fig. 6) . In contrast, when equivalent amounts of nonimmune IgG were substituted for the primary antibodies, TNF-␣ rapidly increased the whole cell current (Fig. 6) . Mean values for the TNF-␣-elicited increases in inward currents for the various experimental conditions shown above are provided in Fig. 7 , with a P value of Ͻ0.005 for the differences.
DISCUSSION
The prior study by Rezaiguia et al. (44) indicated that AFC was upregulated by a TNF-␣-dependent mechanism in acute bacterial pneumonia in rats. A more recent article (10) confirmed that TNF-␣ could augment alveolar epithelial fluid transport in a model of septic peritonitis in rats. However, the mechanism by which TNF-␣ upregulates AFC has not been explored. Our objective was to study the mechanisms that could account for the TNF-␣-induced upregulation of alveolar fluid transport in both intact rats and isolated human alveolar A549 epithelial cells. Some investigators (3, 4, 29, 33) have reported that TNF-␣ can create ion channels by insertion into the plasma membrane as reported in human U937 histiocytic lymphoma cells. In those studies, the effect was enhanced in the presence of a low pH, perhaps because TNF-␣ binding to the TNFRs was markedly decreased in a low pH environment (3, 4) . However, van der Goot et al. (51) reported that membrane insertion is not sufficient for the membrane conductance activating effect of TNF-␣. In the current study, we used a triple-amino acid mutant that does not contain the lectinlike domain of TNF-␣ that is responsible for its membrane conductance effects; the mutant also has a modest decrease in receptor binding (32) .
The major findings of these studies can be summarized as follows. 1) Wild-type TNF-␣ upregulated AFC in rats, a finding consistent with the prior study by Rezaiguia et al. (44) in rats with pneumonia as well as Fig. 4 . A: effect of wild-type TNF-␣ on Na ϩ current in a A549 cell patched in the whole cell mode. The pipette was filled with standard internal solution (see MATERIALS AND METHODS for details). The cell was held at Ϫ40 mV, and an inward current (negative current) was elicited by an application of a Ϫ100-mV pulse. The cell was perfused with either standard external solution (SES) or SES containing TNF-␣ (120 ng/ml) as indicated. B: typical experiment that was repeated 6 times with the same experimental conditions as in A except that the A549 cell was perfused with SES containing 10 M amiloride after perfusion with TNF-␣. Fig. 5 . Effect of triple-mutant TNF-␣ on Na ϩ current in an A549 cell patched in the whole cell mode. The experimental conditions are described in Fig. 4A except that this A549 cell was perfused with SES containing the triple-mutant TNF-␣ (120 ng/ml). In sharp contrast to the result in Fig. 4A , the inward Na ϩ current was not altered during perfusion. Results represent a typical experiment, which was repeated 6 times.
with the recent study of sepsis (10) . 2) Propranolol, a ␤-adrenergic antagonist, did not decrease TNF-␣-stimulated AFC in rats. 3) No additional upregulation occurred with the combination of TNF-␣ and a ␤-adrenergic agonist. 4) Amiloride blocked the TNF-␣-stimulated AFC in rats. 5) The triple-mutant TNF-␣ did not stimulate AFC in rats. 6) In patch-clamp studies of the human alveolar epithelial A549 cell line, TNF-␣ stimulated Na ϩ influx in A549 cells, an effect that was inhibited by amiloride. The triple-mutant TNF-␣ did not induce Na ϩ current in the A549 cells, and the TNFR blocking antibodies abolished the effect of TNF-␣.
Because the effect of TNF-␣ occurred within 30 s from the onset of perfusion in the A549 cells and within 1 h from its instillation in the distal airspaces of the rat, it is apparent that the primary mechanism does not depend on a transcriptional effect of TNF-␣. Because the TNF-␣ effect was inhibitable by amiloride in both the intact rat lung studies and the isolated human A549 epithelial cells, the primary pathway for augmented fluid transport in lung epithelium depends on Na ϩ transport. We then tried to determine whether the TNF-␣ effect could be mediated by an effect on membrane conductance by a receptor-independent mechanism. In a prior study (26) , peritoneal macrophages from TNFR double-knockout mice still showed an increase in ion channel activity in the presence of wildtype TNF-␣, and this activity was amiloride sensitive. Also, a peptide mimicking the lectinlike domain, with no binding to the two TNFRs, can still trigger increases in membrane conductance and also be inhibited by amiloride (33) . Because the triple-mutant TNF-␣ did not stimulate AFC in the rat studies, it seemed plausible that the effect of TNF-␣ was mediated by receptor-independent mechanisms in the lung.
But this interpretation could be incomplete, because the TNF-␣ mutant retains some receptor affinity, although the affinity is decreased 5-fold for TNFR1 and 10-fold for TNFRII (32) . Thus the results of the in vivo studies could be consistent with a receptor-dependent effect, a receptor-independent effect, or both.
Interestingly, the patch-clamp studies in the A549 cells also demonstrated a rapid amiloride-inhibitable uptake of Na ϩ in the presence of wild-type TNF-␣, consistent with the data in the intact rat lung studies. Also, the triple-mutant TNF-␣ did not increase Na ϩ Fig. 7 . Mean values of inward Na ϩ currents elicited after perfusion with wild-type TNF-␣ (120 ng/ml), TNF-␣ (120 ng/ml) in the presence of blocking antibodies to TNFRI and TNFRII (5 ng/ml each), or triple-mutant TNF-␣ (120 ng/ml). Values are means Ϯ SE; n ϭ 6 cells. * P Ͻ 0.005 compared with other groups. currents. An A549 cell was patched in the whole cell mode as described in Fig. 4A and was perfused with SES containing antihuman soluble TNF receptor types I and II (sTNFRI and sTNFRII, respectively) antibodies (5 ng each) for 10 min. When a stable value of the inward Na ϩ current was obtained, the solution was switched to one containing sTNFRI, sTNFRII, and 120 ng/ml of TNF-␣ for ϳ5 min. No change in the inward current was observed. In contrast, when equivalent amounts of nonimmune IgG were substituted for the primary antibodies (B), TNF-␣ rapidly increased the whole cell current. At the end of this period, the cell was perfused with SES containing 10 M amiloride, which blocked the existing Na ϩ current. Results represent a typical experiment, which was repeated 6 times. influx in the A549 cells, also consistent with the results of the rat studies. Therefore, we took advantage of the availability of specific human TNFRI and TNFRII blocking antibodies to determine whether the effect of TNF-␣ in the A549 cells was receptor mediated. The results provided direct evidence in these cells for a receptor-dependent effect. Several studies (39, (46) (47) (48) 50) have shown that TNFRI is expressed in the lung in airway epithelium and alveolar epithelium and that both receptors exist in A549 cells. However, the mechanism by which TNF-␣ increases Na ϩ -dependent AFC in vivo may be considerably more complicated and may involve multiple pathways. TNF-␣ could stimulate the release of other mediators in vivo, such as transforming growth factor-␣ (9, 52), which has been shown to rapidly upregulate AFC in rats (17) . Furthermore, it is certainly plausible that receptor-independent effects may occur in vivo in the lung and that some of the TNF-␣ effects on enhancing alveolar fluid reabsorption across the alveolar epithelium could be secondary to direct effects on the cell membrane.
The combination of TNF-␣ and a ␤-adrenergic agonist, terbutaline, did not have an additive effect on increasing AFC in the TNF-␣-instilled rats. Also, propranolol, a ␤-adrenergic antagonist, did not inhibit the TNF-␣-induced upregulation of alveolar epithelial fluid transport in rats. These results are similar to the findings after instillation of either endotoxin (21) or bacteria (44) into rat lungs. Taken together, the data indicate that TNF-␣-induced alveolar epithelial fluid transport is not mediated by an endogenous release of epinephrine, a finding that is in agreement with the results of a recent peritonitis study in rats (10) .
Which signaling mechanism mediated the TNF-␣-induced Na ϩ uptake? TNF-␣ is known to decrease intracellular cAMP (13, 40) , and the recent study by Börjesson et al. (10) showed that TNF-␣ upregulation of AFC in rats with peritonitis was associated with no change in cAMP in the lung. Therefore, enhanced Na ϩ and fluid transport from TNF-␣ probably does not depend on a cAMP-mediated process. Interestingly, G proteins can mediate several effects of TNF-␣ (25) , and a G protein has been shown to contribute to Na ϩ transport in fetal alveolar type II cells (19, 20, 30, 34) . Also, pertussis toxin can inhibit transepithelial Na ϩ transport (2). However, there is no clear evidence for the association of G protein with an immunopurified alveolar type II cell Na ϩ transport at this time (6). Thus further investigation will be needed to elucidate the mechanisms of TNF-␣ signaling in alveolar epithelial cells.
TNF-␣ has been shown in several studies (11, 49) to increase lung and systemic vascular permeability. Also, in vitro studies indicated that TNF-␣ can alter short-circuit current across cultured alveolar type II cells (56) , and TNF-␣ decreases surfactant protein B expression (43) . Thus TNF-␣ can have a deleterious effect on the lung endothelium and the alveolar epithelium, although the data in this study and other studies (10, 44) documented a beneficial effect of TNF-␣ on lung fluid balance by upregulating alveolar epithelial fluid transport.
In summary, TNF-␣ upregulates alveolar epithelial Na ϩ and fluid transport by an amiloride-sensitive, catecholamine-independent mechanism as demonstrated by studies in both intact rats and isolated human A549 alveolar epithelial cells. In the isolated cell studies, the effect was mediated by a TNFR-dependent process, although the intact rat studies do not clearly distinguish between receptor-dependent and -independent effects of TNF-␣. Overall, these results provide further evidence for a beneficial effect of TNF-␣ on lung fluid balance that may be germane to clinically important pathological conditions such as pneumonia (44) or peritonitis (10) .
